Richard Day

Company: ADM

Job title: Vice President - Medical Affairs & Clinical Development

Seminars:

The Use of a Novel Dual Pro- & Post- Biotic in Adults with IBS-D: Results from a Recent (Unpublished) RCT 4:30 pm

IBS is a hugely important diagnosis, with few effective management options ADM recently completed a 3-arm randomized, double blind placebo controlled clinical trial in adults with IBS-D This talk will cover the full results, including data on IBS symptom severity, abdominal pain scores, quality of life and anxietyRead more

day: Focus Day Track 4